Zoetis Inc (ZTS)
194.81
-0.06
(-0.03%)
USD |
NYSE |
Sep 27, 16:00
194.91
+0.10
(+0.05%)
After-Hours: 20:00
Zoetis Gross Profit (Quarterly): 1.693B for June 30, 2024
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 1.693B |
March 31, 2024 | 1.547B |
December 31, 2023 | 1.485B |
September 30, 2023 | 1.513B |
June 30, 2023 | 1.573B |
March 31, 2023 | 1.412B |
December 31, 2022 | 1.387B |
September 30, 2022 | 1.395B |
June 30, 2022 | 1.427B |
March 31, 2022 | 1.417B |
December 31, 2021 | 1.367B |
September 30, 2021 | 1.404B |
June 30, 2021 | 1.38B |
March 31, 2021 | 1.322B |
December 31, 2020 | 1.206B |
September 30, 2020 | 1.24B |
June 30, 2020 | 1.097B |
March 31, 2020 | 1.075B |
December 31, 2019 | 1.144B |
September 30, 2019 | 1.105B |
June 30, 2019 | 1.082B |
March 31, 2019 | 937.00M |
December 31, 2018 | 1.02B |
September 30, 2018 | 1.007B |
June 30, 2018 | 968.00M |
Date | Value |
---|---|
March 31, 2018 | 919.00M |
December 31, 2017 | 1.003B |
September 30, 2017 | 912.00M |
June 30, 2017 | 829.00M |
March 31, 2017 | 788.00M |
December 31, 2016 | 809.00M |
September 30, 2016 | 831.00M |
June 30, 2016 | 809.00M |
March 31, 2016 | 773.00M |
December 31, 2015 | 778.00M |
September 30, 2015 | 793.00M |
June 30, 2015 | 748.00M |
March 31, 2015 | 708.00M |
December 31, 2014 | 829.00M |
September 30, 2014 | 776.00M |
June 30, 2014 | 745.00M |
March 31, 2014 | 718.00M |
December 31, 2013 | 788.00M |
September 30, 2013 | 718.00M |
June 30, 2013 | 698.00M |
March 31, 2013 | 688.00M |
December 31, 2012 | 743.00M |
September 30, 2012 | 660.00M |
June 30, 2012 | 716.00M |
March 31, 2012 | 654.00M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
1.075B
Minimum
Mar 2020
1.693B
Maximum
Jun 2024
1.359B
Average
1.391B
Median
Gross Profit (Quarterly) Benchmarks
Pfizer Inc | 9.983B |
Alnylam Pharmaceuticals Inc | 591.15M |
Biomarin Pharmaceutical Inc | 581.57M |
Corcept Therapeutics Inc | 161.27M |
Ionis Pharmaceuticals Inc | 221.09M |